NewBiologix
Latest round
- Series A
Last raised
- May 2023
Total raised
- $50M
Investors
- 1
About NewBiologix
Based in Lausanne, Switzerland, and founded in 2022 by CEO Igor Fish and Senior Vice President Nicolas Mermod, NewBiologix SA operates as a developer of a DNA integration technology for cell line creation for gene and cell treatments. NewBiologix SA developed advanced technologies and therapies to improve the field of gene therapy and cell therapy. The company offers technology for gene therapies which is stably engineered HEK that have integrated all genes necessary for rAAV production. In addition, the firm provides Cell-based therapies for improving treatment against the disease, targeted delivery, proliferation, and differentiation into specific body locations. NewBiologix SA provides next-generation sequencing (NGS) which is used to develop a bioinformatics platform that will help cell line engineering through different NGS-based technologies involving short reads, long reads, and optical mapping allowing for exceptionally in-depth datasets composed of a high-coverage sequence assembly.
Who invested in NewBiologix
1 investor across 1 round
See all investors in NewBiologix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 11, 2023
Amount
$50M
Investors
Questions about NewBiologix
Who invested in NewBiologix?
NewBiologix has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NewBiologix raised?
NewBiologix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NewBiologix last raise money?
NewBiologix's most recent round on record is a Series A, in May 2023.
What does NewBiologix do?
Based in Lausanne, Switzerland, and founded in 2022 by CEO Igor Fish and Senior Vice President Nicolas Mermod, NewBiologix SA operates as a developer of a DNA integration technology for cell line creation for gene and cell treatments.
Where is NewBiologix headquartered?
NewBiologix is headquartered in Lausanne, Switzerland.
Which VCs invest in companies like NewBiologix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at NewBiologix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NewBiologix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.